Status:
RECRUITING
Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
Lead Sponsor:
University Hospital Hradec Kralove
Conditions:
COVID-19 Respiratory Infection
Eligibility:
All Genders
18-90 years
Brief Summary
Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load. Several comorbiditi...
Detailed Description
In this pilot study, 30 consecutive COVID-19 patients requiring admission to the hospital due to a moderate and severe COVID-19 infection will be included into an observational study. Following param...
Eligibility Criteria
Inclusion
- SARS CoV2 positive test within last 14 day
- bilateral infiltrates on chest X.ray or CT
- need for oxygen to keep pulse oximetry saturation above 92% or other respiratory support measures (HFNO, non-invasive ventilation or invasive ventilation)
Exclusion
- known history of intersticial lung disease
- known history of congestive heart failure
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04887623
Start Date
April 1 2021
End Date
August 1 2026
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Hradec Kralove
Hradec Králové, Czechia, 50005